Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.

Takanori Kanai, Koji Uraushihara, Teruji Totsuka, Akira Okazawa, Toshifumi Hibi, Shigeru Oshima, Tatsuya Miyata, Tetsuya Nakamura, Mamoru Watanabe

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha, macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophage-derived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

Original languageEnglish
Pages (from-to)131-136
Number of pages6
JournalCurrent drug targets. Inflammation and allergy
Volume2
Issue number2
Publication statusPublished - 2003 Jun
Externally publishedYes

Fingerprint

Interleukin-18
Crohn Disease
Macrophages
Tumor Necrosis Factor-alpha
Therapeutics
Interleukin-12
Inflammatory Bowel Diseases
Immune System
Interleukin-6
Cytokines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pharmacology
  • Immunology

Cite this

Kanai, T., Uraushihara, K., Totsuka, T., Okazawa, A., Hibi, T., Oshima, S., ... Watanabe, M. (2003). Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. Current drug targets. Inflammation and allergy, 2(2), 131-136.

Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. / Kanai, Takanori; Uraushihara, Koji; Totsuka, Teruji; Okazawa, Akira; Hibi, Toshifumi; Oshima, Shigeru; Miyata, Tatsuya; Nakamura, Tetsuya; Watanabe, Mamoru.

In: Current drug targets. Inflammation and allergy, Vol. 2, No. 2, 06.2003, p. 131-136.

Research output: Contribution to journalArticle

Kanai, T, Uraushihara, K, Totsuka, T, Okazawa, A, Hibi, T, Oshima, S, Miyata, T, Nakamura, T & Watanabe, M 2003, 'Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.', Current drug targets. Inflammation and allergy, vol. 2, no. 2, pp. 131-136.
Kanai T, Uraushihara K, Totsuka T, Okazawa A, Hibi T, Oshima S et al. Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. Current drug targets. Inflammation and allergy. 2003 Jun;2(2):131-136.
Kanai, Takanori ; Uraushihara, Koji ; Totsuka, Teruji ; Okazawa, Akira ; Hibi, Toshifumi ; Oshima, Shigeru ; Miyata, Tatsuya ; Nakamura, Tetsuya ; Watanabe, Mamoru. / Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. In: Current drug targets. Inflammation and allergy. 2003 ; Vol. 2, No. 2. pp. 131-136.
@article{19fd79fbf53544f3ad6defde0464e38b,
title = "Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.",
abstract = "Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha, macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophage-derived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.",
author = "Takanori Kanai and Koji Uraushihara and Teruji Totsuka and Akira Okazawa and Toshifumi Hibi and Shigeru Oshima and Tatsuya Miyata and Tetsuya Nakamura and Mamoru Watanabe",
year = "2003",
month = "6",
language = "English",
volume = "2",
pages = "131--136",
journal = "Current Drug Targets: Inflammation and Allergy",
issn = "1871-5281",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.

AU - Kanai, Takanori

AU - Uraushihara, Koji

AU - Totsuka, Teruji

AU - Okazawa, Akira

AU - Hibi, Toshifumi

AU - Oshima, Shigeru

AU - Miyata, Tatsuya

AU - Nakamura, Tetsuya

AU - Watanabe, Mamoru

PY - 2003/6

Y1 - 2003/6

N2 - Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha, macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophage-derived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

AB - Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha, macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophage-derived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=0642344946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642344946&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 131

EP - 136

JO - Current Drug Targets: Inflammation and Allergy

JF - Current Drug Targets: Inflammation and Allergy

SN - 1871-5281

IS - 2

ER -